Ista tobramycin/prednisolone combo
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Ista plans to submit an NDA in the first half of 2006 for a tobramycin/prednisolone combination product for treatment of steroid-responsive inflammatory ocular conditions where risk of bacterial infection exists, the firm says Aug. 4. Ista filed an IND for a Phase III study in the indication during the second quarter...